Miriam Akasbi

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Roser Solans et al. · Lara D. Veeken · 2013 · 243 citations · Full text

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

Pilar Brito‐Zerón, Belchin Kostov, Roser Solans et al. · Annals of the Rheumatic Diseases · 2014 · 193 citations · Full text

Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis

B. Mestre-Gómez, Rosa M. Lorente‐Ramos, Jacobo Rogado et al. · Journal of Thrombosis and Thrombolysis · 2020 · 104 citations · Full text

Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients

M. Pérez-de-Lis, Miriam Akasbi, P. Díez-Cascón et al. · Lupus · 2010 · 92 citations

Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes

Pilar Brito‐Zerón, Soledad Retamozo, Myriam Gandía et al. · Journal of Autoimmunity · 2012 · 88 citations · Full text

Rheumatoid Disorder, Rheumatology, Sjögren Syndrome +12